Equibles does not estimate personal net worth.
Get an email with a short summary when Design Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DSGN alertsPratik Shah, Ph.D. is recorded as CEO at Design Therapeutics, Inc. (DSGN) since August 25, 2023. Design Therapeutics, Inc. reported in an 8-K filed August 25, 2023 that Pratik Shah, Ph.D. was appointed President, Chief Executive Officer and principal financial officer, effective August 25, 2023. Pratik Shah, Ph.D. has spoken on 2 earnings calls across 1 company, most recently for Design Therapeutics, Inc. on November 5, 2025. Design Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Design Therapeutics, Inc. includes Pratik Shah (CEO and Board Member), Sean Jeffries (COO), Dawn Giangiulio (Chief Accounting Officer) and 7 others.
“On August 25, 2023, the Board appointed Pratik Shah, Ph.D., as the Company's President, Chief Executive Officer and principal financial officer.”
“Design is developing a new class of small-molecule genomic medicines. where we have a very unique approach, which is to have molecules that can recognize specific DNA sequences and by doing so can dial up or down individual genes in the genome.”
“Design is developing a new class of small-molecule genomic medicines. where we have a very unique approach, which is to have molecules that can recognize specific DNA sequences and by doing so can dial up or down individual genes in the genome.”
2023-08-25–present
SEC 8-K
2023-08-25–present
Biotechnology · Healthcare
CEO
2023-08-25–present
